Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes
Qizhan Luo, Thomas‐Alexander Vögeli
Cancers (2020) Vol. 12, Iss. 10, pp. 3054-3054
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
Wenhao Ouyang, Yupeng Jiang, Shiyi Bu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 32
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis
Yan Zhuang, Hailong Wang, Da Jiang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 40
A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
Jia Li, Qiao Hao, Fei Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs
Jiaao Yu, Liqiang Lan, Caixin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12737-12754
Closed Access | Times Cited: 7
VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification
Xuedi Xia, Feng Xu, Dexing Dai, et al.
Bioscience Reports (2024) Vol. 44, Iss. 5
Open Access | Times Cited: 2
Construction and validation of transcription‑factor‑based prognostic signature for TACE non‑response and characterization of tumor microenvironment infiltration in hepatocellular carcinoma
Jie Shi, Xin‐Tong Wei, Feng Jiang, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types
Xin-yu Li, Lei Hou, Luyu Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer
Jia Yang, Yuting Zhao, Rongqiang Yuan, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 5
Copy number variation analysis of m6A regulators identified METTL3 as a prognostic and immune‐related biomarker in bladder cancer
Xiaoshuai Wang, Jingwei Yu, Jinbao Chen, et al.
Cancer Medicine (2021) Vol. 10, Iss. 21, pp. 7804-7815
Open Access | Times Cited: 11
Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer
Zhen Ye, Guangle Song, Jianwei Liang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis
Qing-Tai Dong, Dan-Dan Ma, Qi Hua Gong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus
Huiyan Li, Pingting Yang
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Pan-cancer analysis of the DNA methylation patterns of long non-coding RNA
Shijia Wang, Rendong Wang, Fang Gao, et al.
Genomics (2022) Vol. 114, Iss. 4, pp. 110377-110377
Open Access | Times Cited: 6
Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA
Zexi He, Jun Gu, Ting Luan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: From the commercially available to new prospective candidates
Xuan‐Mei Piao, Ho-Won Kang, Wun‐Jae Kim, et al.
Investigative and Clinical Urology (2021) Vol. 62, Iss. 5, pp. 500-500
Open Access | Times Cited: 6
Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma
Bo Tu, Ling Ye, Qingsong Cao, et al.
Hereditas (2022) Vol. 159, Iss. 1
Open Access | Times Cited: 4
Molecular Subgroup Classification in Alzheimer’s Disease by Transcriptomic Profiles
Sha Liu, Yan Lü, Deqin Geng
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 4, pp. 866-879
Closed Access | Times Cited: 4
Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma
Yu Wang, Tongjun Song, Kai Li, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 4
An Exploration of the Tumor Microenvironment Identified a Novel Five-Gene Model for Predicting Outcomes in Bladder Cancer
Xinjie Li, Jiahao Feng, Yazhou Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma
Hao Zhang, Juntang Lin, Badrul Hisham Yahaya
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
Overexpression of ferroptosis-related gene NFS1 correlates with gastric cancer progression and tumor immune infiltration
Zhiyun Mao, Zhongmei Shi, Ming Cui, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
Shuai Ma, Fang Wang, Nan Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 2
Reclassification of Kidney Clear Cell Carcinoma Based on Immune Cell Gene-Related DNA CpG Pairs
Qizhan Luo, Thomas‐Alexander Vögeli
Biomedicines (2021) Vol. 9, Iss. 2, pp. 215-215
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top